LivaNova raises 2026 constant-currency revenue growth forecast to 9%-10%
LIVN•LivaNova raised its 2026 constant-currency revenue growth forecast to 9%-10% from 8%-9% and adjusted diluted earnings guidance to $4.40-$4.50 per share from $4.30-$4.40. It reported third-quarter revenue of $393.1 million, up 10% in constant currencies.
1. Raised 2026 outlook
LivaNova raised its 2026 constant-currency revenue growth forecast to 9%-10% from 8%-9% on November 4. Adjusted diluted earnings guidance increased to $4.40-$4.50 per share from $4.30-$4.40.
2. Other targets unchanged
The company kept adjusted operating margin guidance at 20%-21% and adjusted free cash flow guidance at $140 million-$160 million. Capital spending remains projected at $135 million to support innovation, growth and IT infrastructure.
3. Third-quarter revenue
Third-quarter revenue was $393.1 million, up 10% in constant currencies, driven by demand in Cardiopulmonary and Epilepsy.
